NCT06375005: Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis
- State
- Under way
- Phase
- Phase 2
- People
- 38 planned
- Started
- 6 Jan 2025
- Primary completion
- 6 Jan 2027
- Arms
- Mycophenolate Mofetil + Telitacicept
- Results
- None posted
- 19 Apr 2024: Trial registered
- 6 Jan 2025: Trial started